Nasdaq.comUS
Aldeyra Therapeutics, Inc. Receives Nasdaq Notice Regarding $1.00 Minimum Bid Price Requirement
On November 17, 2026, Aldeyra Therapeutics, Inc. received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market indicating that as result of the closing bid…